Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -7.50% is 87% above its 5-year average of -59.32%, near the high end of its 5-year range (-209.93%–-7.50%).
As of the fiscal period ended Tuesday, June 30, 2026. 79.76% above its 12-month average of -37.06%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -7.50%.
RETURN ON EQUITY (ROE)
-7.50%
RETURN ON EQUITY (ROE) AVG TTM
-37.06%
RETURN ON EQUITY (ROE) AVG 3Y
-81.59%
RETURN ON EQUITY (ROE) AVG 5Y
-59.32%
RETURN ON EQUITY (ROE) AVG 10Y
-45.44%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+79.76%
CURRENT VS 3Y AVG
+90.81%
CURRENT VS 5Y AVG
+87.36%
CURRENT VS 10Y AVG
+83.50%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
+82.15%
vs the sector median at left
iRhythm Technologies, Inc.
Market Cap
$3.56B
Return on Equity (ROE)
-7.50%
TTM Avg
-37.06%
3Y Avg
-81.59%
5Y Avg
-59.32%
Market Cap
$3.56B
Return on Equity (ROE)
8.25%
TTM Avg
3.56%
3Y Avg
-0.85%
5Y Avg
-3.10%
Market Cap
$3.52B
Return on Equity (ROE)
-32.94%
TTM Avg
-45.25%
3Y Avg
-31.88%
5Y Avg
-26.45%
Market Cap
$3.51B
Return on Equity (ROE)
-12.08%
TTM Avg
-47.33%
3Y Avg
-44.55%
5Y Avg
-54.96%
Market Cap
$3.49B
Return on Equity (ROE)
-14.60%
TTM Avg
-18.51%
3Y Avg
-18.00%
5Y Avg
-17.65%
Market Cap
$3.49B
Return on Equity (ROE)
N/A
TTM Avg
-136.37%
3Y Avg
-87.14%
5Y Avg
-78.77%
Market Cap
$3.44B
Return on Equity (ROE)
-80.46%
TTM Avg
-68.44%
3Y Avg
592.63%
5Y Avg
329.15%
Market Cap
$3.39B
Return on Equity (ROE)
29.12%
TTM Avg
31.38%
3Y Avg
-1.34%
5Y Avg
-13.55%
Market Cap
$3.38B
Return on Equity (ROE)
26.08%
TTM Avg
3.42%
3Y Avg
-20.94%
5Y Avg
-16.18%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| iRhythm Technologies, Inc. (IRTC) | $3.56B | -7.50% | -37.06% | -81.59% | -59.32% |
| Veracyte, Inc. (VCYT)vs › | $3.56B | 8.25% | 3.56% | -0.85% | -3.10% |
| Xenon Pharmaceuticals Inc. (XENE)vs › | $3.52B | -32.94% | -45.25% | -31.88% | -26.45% |
| Tango Therapeutics, Inc. (TNGX)vs › | $3.51B | -12.08% | -47.33% | -44.55% | -54.96% |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.49B | -14.60% | -18.51% | -18.00% | -17.65% |
| Celcuity Inc. (CELC)vs › | $3.49B | N/A | -136.37% | -87.14% | -78.77% |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.44B | -80.46% | -68.44% | 592.63% | 329.15% |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.39B | 29.12% | 31.38% | -1.34% | -13.55% |
| CareDx, Inc (CDNA)vs › | $3.38B | 26.08% | 3.42% | -20.94% | -16.18% |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.32B | N/A | 336.99% | 336.99% | 336.99% |
ROE
-7.5%
ROA
-1.3%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -7.50% |
| 2026-03-31 | -17.23% |
| 2025-12-31 | -29.17% |
| 2025-09-30 | -42.22% |
| 2025-06-30 | -89.17% |
| 2025-03-31 | -113.45% |
| 2024-12-31 | -124.62% |
| 2024-09-30 | -209.93% |
| 2024-06-30 | -132.66% |
| 2024-03-31 | -143.94% |
| 2023-12-31 | -58.74% |
| 2023-09-30 | -47.73% |
| 2023-06-30 | -44.33% |
| 2023-03-31 | -47.18% |
| 2022-12-31 | -48.44% |
| 2022-09-30 | -53.69% |
| 2022-06-30 | -53.44% |
| 2022-03-31 | -50.72% |
| 2021-12-31 | -36.26% |
| 2021-09-30 | -26.54% |
| 2021-06-30 | -19.41% |
| 2021-03-31 | -20.20% |
| 2020-12-31 | -12.83% |
| 2020-09-30 | -15.39% |
| 2020-06-30 | -55.19% |
| 2020-03-31 | -44.31% |
| 2019-12-31 | -40.30% |
| 2019-09-30 | -36.09% |
| 2019-06-30 | -89.32% |
| 2019-03-31 | -90.29% |
| 2018-12-31 | -87.76% |
| 2018-09-30 | -69.11% |
| 2018-06-30 | -59.88% |
| 2018-03-31 | -48.52% |
| 2017-12-31 | -36.98% |
| 2017-09-30 | -28.74% |
| 2017-06-30 | -25.26% |
| 2017-03-31 | -22.48% |
| 2016-12-31 | -22.58% |
| 2015-09-30 | -342.62% |